Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis
Firoozeh V. Gerayeli, Stephen Milne, Chung Yan Cheung, et al.
EClinicalMedicine (2021) Vol. 33, pp. 100789-100789
Open Access | Times Cited: 250

Showing 1-25 of 250 citing articles:

Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019
Saeid Safiri, Kristin Carson‐Chahhoud, Maryam Noori, et al.
BMJ (2022), pp. e069679-e069679
Open Access | Times Cited: 491
Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis
Jaber S. Alqahtani, Tope Oyelade, Abdulelah M. Aldhahir, et al.
PLoS ONE (2021) Vol. 16, Iss. 8, pp. e0255659-e0255659
Open Access | Times Cited: 281
NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries
David Watkins, William Msemburi, Sarah Pickersgill, et al.
The Lancet (2022) Vol. 399, Iss. 10331, pp. 1266-1278
Open Access | Times Cited: 139
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 71
Hesitant or Not Hesitant? A Systematic Review on Global COVID-19 Vaccine Acceptance in Different Populations
Maria Giulia Salomoni, Zeno Di Valerio, Elisa Gabrielli, et al.
Vaccines (2021) Vol. 9, Iss. 8, pp. 873-873
Open Access | Times Cited: 99
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study
Carlo Fumagalli, Chiara Zocchi, Luigi Tassetti, et al.
European Journal of Internal Medicine (2021) Vol. 97, pp. 36-41
Open Access | Times Cited: 84
Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis
Ram Prasad, Michael J. Patton, Jason L. Floyd, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9141-9141
Open Access | Times Cited: 59
Increased SARS-CoV-2 Infection, Protease, and Inflammatory Responses in Chronic Obstructive Pulmonary Disease Primary Bronchial Epithelial Cells Defined with Single-Cell RNA Sequencing
Matt D. Johansen, Rashad Mohammad Mahbub, Sobia Idrees, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 206, Iss. 6, pp. 712-729
Open Access | Times Cited: 47
Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States
Lena F. Schimke, Alexandre H. C. Marques, G. Baiocchi, et al.
Cells (2022) Vol. 11, Iss. 5, pp. 847-847
Open Access | Times Cited: 39
Supersulphides provide airway protection in viral and chronic lung diseases
Tetsuro Matsunaga, Hirohito Sano, Katsuya Takita, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 35
COVID-19, Mental Health, and Chronic Illnesses: A Syndemic Perspective
Kiran Saqib, Afaf Saqib Qureshi, Zahid A Butt
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3262-3262
Open Access | Times Cited: 28
The Complex Association between COPD and COVID-19
Nikhil T Awatade, Peter Wark, Andrew S. L. Chan, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3791-3791
Open Access | Times Cited: 25
Predictive Potential of Retina‐Based Biological Age in Assessing Chronic Obstructive Pulmonary Disease Risk
Qingsheng Peng, Tyler Hyungtaek Rim, Zhi Da Soh, et al.
Clinical and Experimental Ophthalmology (2025)
Open Access | Times Cited: 1
Vaccine Hesitancy towards COVID-19 Vaccination: Investigating the Role of Information Sources through a Mediation Analysis
Chiara Reno, Elisa Maietti, Zeno Di Valerio, et al.
Infectious Disease Reports (2021) Vol. 13, Iss. 3, pp. 712-723
Open Access | Times Cited: 54
Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients
Donato Lacedonia, Giulia Scioscia, Carla Santomasi, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 44
Association of smoking, lung function and COPD in COVID‐19 risk: a two‐step Mendelian randomization study
Shiu Lun Au Yeung, Albert Martin Li, Baoting He, et al.
Addiction (2022) Vol. 117, Iss. 7, pp. 2027-2036
Open Access | Times Cited: 34
A Pandemic Lesson for Global Lung Diseases: Exacerbations Are Preventable
William Cookson, Miriam F. Moffatt, Garth Rapeport, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 205, Iss. 11, pp. 1271-1280
Open Access | Times Cited: 31
Identifying pre-existing conditions and multimorbidity patterns associated with in-hospital mortality in patients with COVID-19
Magda Bucholc, Declan Bradley, Damien Bennett, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 31
Epidemiology, Healthcare Resource Utilization, and Mortality of Asthma and COPD in COVID-19: A Systematic Literature Review and Meta-Analyses
David Halpin, Adrian Paul J. Rabe, Wei Jie Loke, et al.
Journal of Asthma and Allergy (2022) Vol. Volume 15, pp. 811-825
Open Access | Times Cited: 29
COVID-19 Vaccinations: A Comprehensive Review of Their Safety and Efficacy in Special Populations
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Vaccines (2021) Vol. 9, Iss. 10, pp. 1097-1097
Open Access | Times Cited: 39
Coronavirus disease 2019 (Covid‐19) vaccination recommendations in special populations and patients with existing comorbidities
Zeinab Mohseni Afshar, Arefeh Babazadeh, Alireza Janbakhsh, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 3
Open Access | Times Cited: 37
Impact of COVID-19 on Hospital Admissions for COPD Exacerbation: Lessons for Future Care
Michael Lawless, Mark Burgess, Stephen C Bourke
Medicina (2022) Vol. 58, Iss. 1, pp. 66-66
Open Access | Times Cited: 28
COVID-19 infection in patients with chronic obstructive pulmonary disease: From pathophysiology to therapy. Mini-review
Mónika Fekete, Z Szarvas, Vince Fazekas‐Pongor, et al.
Physiology International (2022) Vol. 109, Iss. 1, pp. 9-19
Open Access | Times Cited: 25
The establishment of COPD organoids to study host-pathogen interaction reveals enhanced viral fitness of SARS-CoV-2 in bronchi
Louisa L. Y. Chan, Danielle E. Anderson, Hong Sheng Cheng, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 25
COVID-19 Severity and Mortality in Veterans with Chronic Lung Disease
Kristina Crothers, Scott V. Adams, Aaron P. Turner, et al.
Annals of the American Thoracic Society (2024) Vol. 21, Iss. 7, pp. 1034-1043
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top